Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

P-glycoprotein (Pgp) does not affect the cytotoxicity of flavonoids from Sophora flavescens, which also have no effects on Pgp action.

Choi SU, Kim KH, Choi EJ, Park SH, Lee CO, Jung NP, Yoon SK, Ryu SY.

Anticancer Res. 1999 May-Jun;19(3A):2035-40.

PMID:
10470145
3.

Psammaplin A, a natural phenolic compound, has inhibitory effect on human topoisomerase II and is cytotoxic to cancer cells.

Kim D, Lee IS, Jung JH, Lee CO, Choi SU.

Anticancer Res. 1999 Sep-Oct;19(5B):4085-90.

PMID:
10628358
4.

Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864), a new camptothecin analogue.

Hendricks CB, Rowinsky EK, Grochow LB, Donehower RC, Kaufmann SH.

Cancer Res. 1992 Apr 15;52(8):2268-78.

5.

The bisbenzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance-related drugs via modulation of P-glycoprotein.

Choi SU, Park SH, Kim KH, Choi EJ, Kim S, Park WK, Zhang YH, Kim HS, Jung NP, Lee CO.

Anticancer Drugs. 1998 Mar;9(3):255-61.

PMID:
9625436
6.

Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.

Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV, Limtrakul PN.

Biochem Pharmacol. 2002 Aug 15;64(4):573-82.

PMID:
12167476
7.

Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.

Stein U, Walther W, Shoemaker RH.

J Natl Cancer Inst. 1996 Oct 2;88(19):1383-92.

PMID:
8827016
8.

Effects of flavonoids on the growth and cell cycle of cancer cells.

Choi SU, Ryu SY, Yoon SK, Jung NP, Park SH, Kim KH, Choi EJ, Lee CO.

Anticancer Res. 1999 Nov-Dec;19(6B):5229-33.

PMID:
10697540
9.

The cytotoxic effect and the multidrug resistance reversing action of lignans from Phyllanthus amarus.

Leite DF, Kassuya CA, Mazzuco TL, Silvestre A, de Melo LV, Rehder VL, Rumjanek VM, Calixto JB.

Planta Med. 2006 Dec;72(15):1353-8. Epub 2006 Oct 20.

PMID:
17054045
10.

Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.

Rieger L, Rieger J, Winter S, Streffer J, Esser P, Dichgans J, Meyermann R, Weller M.

Acta Neuropathol. 2000 May;99(5):555-62.

PMID:
10805101
11.

Modulation of P-glycoprotein mediated drug accumulation in multidrug resistant CCRF VCR-1000 cells by chemosensitisers.

Boer R, Gekeler V, Ulrich WR, Zimmermann P, Ise W, Schödl A, Haas S.

Eur J Cancer. 1996 May;32A(5):857-61.

PMID:
9081366
12.

Growth inhibition by dehydrothyrsiferol - a non-Pgp modulator, derived from a marine red alga - in human breast cancer cell lines.

Pec MK, Moser-Thier K, Fernández JJ, Souto ML, Kubista E.

Int J Oncol. 1999 Apr;14(4):739-43.

PMID:
10087323
13.

Novel multidrug-resistance modulators, KR-30026 and KR-30031, in cancer cells.

Choi SU, Lee BH, Kim KH, Choi EJ, Park SH, Shin HS, Yoo SE, Jung NP, Lee CO.

Anticancer Res. 1997 Nov-Dec;17(6D):4577-82.

PMID:
9494571
14.

Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes.

Fong WF, Wan CK, Zhu GY, Chattopadhyay A, Dey S, Zhao Z, Shen XL.

Planta Med. 2007 Mar;73(3):212-20. Epub 2007 Feb 22.

PMID:
17318783
15.

Reversal of multidrug resistance by novel verapamil analogs in cancer cells.

Choi SU, Lee CO, Kim KH, Choi EJ, Park SH, Shin HS, Yoo SE, Jung NP, Lee BH.

Anticancer Drugs. 1998 Feb;9(2):157-65.

PMID:
9510502
16.
17.

Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity.

Broxterman HJ, Sonneveld P, Feller N, Ossenkoppele GJ, Währer DC, Eekman CA, Schoester M, Lankelma J, Pinedo HM, Löwenberg B, Schuurhuis GJ.

Blood. 1996 Jun 1;87(11):4809-16.

19.

Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.

Scala S, Dickstein B, Regis J, Szallasi Z, Blumberg PM, Bates SE.

Clin Cancer Res. 1995 Dec;1(12):1581-7.

20.

Multidrug resistance in androgen-independent growing rat prostate carcinoma cells is mediated by P-glycoprotein.

Siegsmund MJ, Kreukler C, Steidler A, Nebe T, Köhrmann KU, Alken P.

Urol Res. 1997;25(1):35-41.

PMID:
9079744

Supplemental Content

Support Center